Product Description: THR-β agonist 2 diacetate (Compound 3) is a potent agonist of THR-β. THR-β agonist 2 diacetate has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases[1].
Applications: Metabolism-sugar/lipid metabolism
Formula: C22H16Cl2N6O8
References: [1]Fanglong Yang, et al. Heterocyclic derivatives, their preparation methods and their application in medicine. Patent WO2021121210A1.
Molecular Weight: 563.30
Research Area: Metabolic Disease
Target: Thyroid Hormone Receptor